NextCure, Inc. (NXTC)
$5.89-6.36%Close
BUYCRISIS · day 5
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $21M
- Avg volume
- 2.1M
- Beta
- 1.27
- P/E (TTM)
- -0.56
- Short % float
- 6.25%
- Days to cover
- 1.0
- SI change
- -89.3%
- 1W
- -23.61%
- 1M
- +38.92%
- 3M
- -24.78%
- YTD
- -55.65%
- vs SPY 1W
- -22.42%
- vs SPY 1M
- +35.59%
- vs SPY 3M
- -27.17%
- vs SPY YTD
- -67.40%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- COGTSELLCogent Biosciences, Inc.BEARQ 14$36.23-1.36%
- DRTSBUYAlpha Tau Medical Ltd.BULLQ 16$14.70-1.47%
- ZNTLSELLZentalis Pharmaceuticals, Inc.CRISISQ -5$3.76-1.83%
- DCOYSELLDecoy Therapeutics Inc.CRISISQ -24$3.11-2.81%
- AARDSELLAardvark Therapeutics, Inc. Common StockRECOVERYQ -15$6.88+0.88%
- AGMBBUYAgomAb Therapeutics N.V. American Depositary SharesQ -8$12.82-3.25%
- INTSBUYIntensity Therapeutics, Inc.RECOVERYQ -17$4.75-2.26%
- CRLBUYCharles River Laboratories International, Inc.BULLQ 12$298.58+1.15%
- PLSMSELLPulsenmore Ltd. Ordinary SharesQ -32$2.79-5.10%
- RXSTBUYRxSight, Inc.BEARQ -10$6.26+0.16%
- NRCBUYNational Research CorporationRECOVERYQ 3$21.92-1.22%
- CTKBBUYCytek Biosciences, Inc.RECOVERYQ -10$4.44-7.69%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 17
- VALUE
- 15
- GROWTH
- 43
- GARP
- 5
- TYPE
- Value / Recovery (blended)
Composite of Value · Growth · GARP
ROIC-105.3%
REV YoY-
ROE-175.5%
EPS YoY-
ROA-189.0%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.56
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B2.57
P/FCF-
EV/EBITDA-0.25
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E35.29
ALTMAN Z-
CURR RATIO3.47
ND/EBITDA-
BETA1.27
